HROMADKA, Milan, Zuzana MOTOVSKA, Ota HLINOMAZ, Petr KALA, Ivo VARVAROVSKY, Jaroslav DUSEK, Michal SVOBODA, Jiří JARKOVSKÝ, Frantisek TOUSEK, Pavel JANSKY, Stanislav SIMEK, Marian BRANNY, Jan MROZEK, Roman MIKLÍK, Richard ROKYTA and Petr WIDIMSKY. The relationship between symptom onset-to-needle time and ischemic outcomes in patients with acute myocardial infarction treated with primary PCI Observations from Prague-18 Study. JOURNAL OF CARDIOLOGY. NETHERLANDS: ELSEVIER, 2022, vol. 79, No 5, p. 1-8. ISSN 0914-5087. Available from: https://dx.doi.org/10.1016/j.jjcc.2021.11.015. |
Other formats:
BibTeX
LaTeX
RIS
@article{2247545, author = {Hromadka, Milan and Motovska, Zuzana and Hlinomaz, Ota and Kala, Petr and Varvarovsky, Ivo and Dusek, Jaroslav and Svoboda, Michal and Jarkovský, Jiří and Tousek, Frantisek and Jansky, Pavel and Simek, Stanislav and Branny, Marian and Mrozek, Jan and Miklík, Roman and Rokyta, Richard and Widimsky, Petr}, article_location = {NETHERLANDS}, article_number = {5}, doi = {http://dx.doi.org/10.1016/j.jjcc.2021.11.015}, keywords = {Acute myocardial infarction; Symptoms onset to needle time; Risk stratification; P2Y12 inhibitors; Ischemic endpoints}, language = {eng}, issn = {0914-5087}, journal = {JOURNAL OF CARDIOLOGY}, title = {The relationship between symptom onset-to-needle time and ischemic outcomes in patients with acute myocardial infarction treated with primary PCI Observations from Prague-18 Study}, url = {https://www.sciencedirect.com/science/article/pii/S0914508721003385?via%3Dihub}, volume = {79}, year = {2022} }
TY - JOUR ID - 2247545 AU - Hromadka, Milan - Motovska, Zuzana - Hlinomaz, Ota - Kala, Petr - Varvarovsky, Ivo - Dusek, Jaroslav - Svoboda, Michal - Jarkovský, Jiří - Tousek, Frantisek - Jansky, Pavel - Simek, Stanislav - Branny, Marian - Mrozek, Jan - Miklík, Roman - Rokyta, Richard - Widimsky, Petr PY - 2022 TI - The relationship between symptom onset-to-needle time and ischemic outcomes in patients with acute myocardial infarction treated with primary PCI Observations from Prague-18 Study JF - JOURNAL OF CARDIOLOGY VL - 79 IS - 5 SP - 1-8 EP - 1-8 PB - ELSEVIER SN - 09145087 KW - Acute myocardial infarction KW - Symptoms onset to needle time KW - Risk stratification KW - P2Y12 inhibitors KW - Ischemic endpoints UR - https://www.sciencedirect.com/science/article/pii/S0914508721003385?via%3Dihub N2 - Objectives: Based on previous studies with clopidogrel, the time between acute myocardial infarction (AMI) symptoms onset and primary percutaneous coronary intervention (PCI) was proven as important prognostic factor. Our aim was to assess the relationship between symptoms onset to needle time (SNT) and procedural results and the occurrence of ischemic endpoints in primary angioplasty patients treated with potent P2Y12 inhibitors. Methods: A total of 1,131 out of 1,230 patients randomized to the Prague-18 study (prasugrel vs. ticagrelor in primary PCI) were divided into a high and a low-risk group. The effect of defined SNT on patients' ischemic endpoints and prognosis by their risk status at admission was tested. Results: The median SNT was 3.2 hours. Longer SNTs resulted in a more frequent incidence of TIMI flow <3 post PCI (p=0.015). There were significant differences in the occurrence of the combined ischemic endpoint among the compared SNT groups at 30 days (p=0.032), and 1 year (p=0.011), with the highest incidence in the <<= 1 h SNT group of patients. "Latecomers" (SNT>4 hs) in the high-risk group experienced more reinfarction within 1 year [OR (95% CI) 3.23 (1.09-9.62) p=0.035]; no difference was found in the low-risk group. Conclusions: In the era of intense antithrombotic medication, stratification of MI patients undergoing primary angioplasty, based on initial ischemic risk assessment affected prognosis more than symptom onset to needle time. Longer time delay was significantly related to increased incidence of ischemic events and all-cause mortality only in patients with high ischemic risk. (C) 2021 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved. ER -
HROMADKA, Milan, Zuzana MOTOVSKA, Ota HLINOMAZ, Petr KALA, Ivo VARVAROVSKY, Jaroslav DUSEK, Michal SVOBODA, Jiří JARKOVSKÝ, Frantisek TOUSEK, Pavel JANSKY, Stanislav SIMEK, Marian BRANNY, Jan MROZEK, Roman MIKLÍK, Richard ROKYTA and Petr WIDIMSKY. The relationship between symptom onset-to-needle time and ischemic outcomes in patients with acute myocardial infarction treated with primary PCI Observations from Prague-18 Study. \textit{JOURNAL OF CARDIOLOGY}. NETHERLANDS: ELSEVIER, 2022, vol.~79, No~5, p.~1-8. ISSN~0914-5087. Available from: https://dx.doi.org/10.1016/j.jjcc.2021.11.015.
|